DNAnexus

The financing, led by new investor Foresite Capital, will help DNAnexus deploy its genome informatics technology and expand its clinical trials presence.

DNAnexus is running a pilot on its genome informatics platform with Google's newly open-sourced DeepVariant variant calling tool.

Under the partnership, DNAnexus customers will have direct access to the Dragen Genome Pipeline for "ultra-rapid" genome analysis.

Vendors DNAnexus and Saphetor hope to create a seamless platform for genome-based biomarker discovery and interpretation.

The AstraZeneca Centre for Genomics Research has tapped DNAnexus to develop a secure genomics informatics environment for analyzing 2 million genomes.

Researchers participating in ORIEN's Avatar program can use the platform to manage, share, integrate, and analyze molecular data from consenting patients.

The WGS service will be provided by Genome.One, a new health information company owned by and based at the Garvan Institute of Medical Research in Sydney.